SSTR2 and neoplasm: In about fifty different human sstr2-positive successive tumor sections 177Lu-DOTA-BASS had higher binding capacity than 177Lu-DOTA-TATE, with mean ratios of antagonist-to-agonist ranged from 4.2 up to 12.3, as shown using in vitro receptor autoradiography [29].